Exhibit 3(o)


                           AMENDMENT TO BYLAWS OF
                         K-V PHARMACEUTICAL COMPANY

As directed by the unanimously adopted resolution of the Board of Directors
of K-V Pharmaceutical Company duly adopted on June 28, 2004, the Bylaws of
the Company were amended, effective June 28, 2004, by amending the first
sentence of Article III, Section 1 thereof to read as follows in its
entirety:

     "The number of directors which shall constitute the whole board shall
be ten."